Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the founders and the current owners in connection with Altor’s investment in global fashion house Totême
Mandate

Vinge advises the founders and the current owners in connection with Altor’s investment in global fashion house Totême

May 21, 2021 M&A

Vinge advises the founders and other existing shareholders in connection with Altor Fund V’s investment in the global fashion house Totême. The founders will remain as majority shareholders and continue in their current roles in the development of Totême. Altor will support the founders and the company on its continued international growth journey.

Founded by Elin Kling and Karl Lindman in 2014 in New York City, Totême is a fast-growing fashion label in the modern luxury universe, widely known for their iconic uniforms. The company is headquartered in Stockholm with a strong Swedish heritage but with a true global presence. Sales are evenly split between Asia, North America and Europe, with a predominantly online presence via its own web shop and online retailers.

Vinge’s team consisted of Jonas Bergström, Karl Klackenberg and Hannah Kajlinger (M&A) as well as Viktoria Owetz Leyva (VDR Specialist).

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025